RxDoctor Payments Data

Shannon Sozzi

Psychiatric/Mental Health · Greenville, SCNPI 1538578232

Payments from drug & device makers

$1,453in general payments, 2019–2025

Across 81 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$269
  • Teva Pharmaceuticals USA, Inc.$256
  • Johnson & Johnson$168
  • Alkermes, Inc.$164
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$156
  • Vanda Pharmaceuticals Inc.$153
  • plus $287 from 8 others

What the payments were for

  • Food & beverage$1,453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,453 in reported general payments places this provider in the 65th percentile of 354 psychiatric/mental health providers in South Carolina.

See all psychiatric/mental health providers in South Carolina

Medicare billing

Part B allowed, 2024
$6,565
Medicare patients
12
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole12$8,337
VyvanseLisdexamfetamine Dimesylate11$3,991
Bupropion XlBupropion Hcl29$913
Lurasidone Hcl12$513
Trazodone Hcl47$368
Divalproex Sodium ErDivalproex Sodium13$333
Ziprasidone Hcl20$331
Lorazepam57$281
Lamotrigine15$253
Sertraline Hcl43$236
Venlafaxine Hcl ErVenlafaxine Hcl23$178
Amitriptyline Hcl11$161
Gabapentin15$158
Lithium Carbonate ErLithium Carbonate11$99

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$21$3,99111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 354 psychiatric/mental health providers in South Carolina.

Other psychiatric/mental health in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →